The evolving role of metabolic and bariatric surgery in contemporary clinical practice - Summary - MDSpire

The evolving role of metabolic and bariatric surgery in contemporary clinical practice

  • By

  • Giorgia Panichella

  • Francesco Gentile

  • Monica Nannipieri

  • Michele Emdin

  • December 26, 2025

  • 0 min

Share

Objective:

To describe the role of metabolic and bariatric surgery (MBS) in contemporary clinical practice, emphasizing the significance of the evolving landscape of pharmacological approaches to treat obesity.

Key Findings:
  • MBS is the most effective long-term treatment for severe obesity and its comorbidities.
  • MBS leads to improved glycaemic control, lower apnoea burden, reduced cardiovascular risk, and improved survival.
  • Emerging weight-loss medications like GLP-1 receptor agonists and tirzepatide may influence referral patterns for MBS.
  • MBS has limitations including perioperative risks, nutritional deficiencies, and variable access across healthcare systems.
Interpretation:

The integration of MBS with novel pharmacological treatments is essential for optimizing patient selection and therapeutic pathways in obesity management, highlighting their complementary roles.

Limitations:
  • Short-term risks of MBS include complications and nutritional deficiencies.
  • Long-term challenges include weight regain and the need for lifelong micronutrient supplementation.
  • Limited uptake of MBS due to referral patterns, patient preferences, and insurance coverage, which can hinder effective treatment.
Conclusion:

MBS remains a critical intervention for severe obesity, but its role may evolve with the advent of effective pharmacotherapy, necessitating a collaborative approach in treatment strategies.

Original Source(s)

The evolving role of metabolic and bariatric surgery in contemporary clinical practice

  • by Giorgia Panichella, Francesco Gentile, Monica Nannipieri, Michele Emdin

  • December 26, 2025

Related Content

A Smarter Screen for Sleep Apnea Stimulation

A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min
Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.